LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $279,946 | -14.8% | 4,672 | +2.5% | 0.00% | -33.3% |
| Q2 2023 | $328,560 | -8.8% | 4,557 | -6.9% | 0.00% | 0.0% |
| Q1 2023 | $360,076 | +13.2% | 4,895 | +2.8% | 0.00% | 0.0% |
| Q4 2022 | $318,168 | -19.5% | 4,763 | +4.0% | 0.00% | -25.0% |
| Q3 2022 | $395,000 | -2.2% | 4,582 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $404,000 | -20.5% | 4,529 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $508,000 | -26.7% | 4,517 | +0.6% | 0.00% | -20.0% |
| Q4 2021 | $693,000 | +9.7% | 4,488 | -1.1% | 0.01% | 0.0% |
| Q3 2021 | $632,000 | +6.8% | 4,536 | +0.4% | 0.01% | 0.0% |
| Q2 2021 | $592,000 | -17.1% | 4,516 | -3.5% | 0.01% | -16.7% |
| Q1 2021 | $714,000 | +54.2% | 4,681 | +0.5% | 0.01% | +50.0% |
| Q4 2020 | $463,000 | +0.2% | 4,660 | -3.8% | 0.00% | -20.0% |
| Q3 2020 | $462,000 | +10.8% | 4,842 | +30.0% | 0.01% | -16.7% |
| Q2 2020 | $417,000 | +39.0% | 3,725 | -9.7% | 0.01% | +20.0% |
| Q1 2020 | $300,000 | -71.1% | 4,123 | -58.6% | 0.01% | -61.5% |
| Q4 2019 | $1,039,000 | -11.9% | 9,959 | -15.9% | 0.01% | -7.1% |
| Q3 2019 | $1,179,000 | -27.4% | 11,848 | -16.7% | 0.01% | -26.3% |
| Q2 2019 | $1,624,000 | -12.0% | 14,224 | -3.1% | 0.02% | -13.6% |
| Q1 2019 | $1,846,000 | -10.8% | 14,681 | -3.8% | 0.02% | -18.5% |
| Q4 2018 | $2,070,000 | -75.4% | 15,255 | -50.2% | 0.03% | -65.8% |
| Q3 2018 | $8,403,000 | +30.7% | 30,614 | -1.4% | 0.08% | +21.5% |
| Q2 2018 | $6,430,000 | +17.0% | 31,037 | -6.7% | 0.06% | +18.2% |
| Q1 2018 | $5,495,000 | +13.1% | 33,273 | -6.2% | 0.06% | +17.0% |
| Q4 2017 | $4,857,000 | +228.0% | 35,473 | +226.2% | 0.05% | +161.1% |
| Q3 2017 | $1,481,000 | +22.3% | 10,875 | +9.0% | 0.02% | +5.9% |
| Q2 2017 | $1,211,000 | +15.9% | 9,975 | +1.0% | 0.02% | +13.3% |
| Q1 2017 | $1,045,000 | +5.2% | 9,875 | +1.0% | 0.02% | 0.0% |
| Q4 2016 | $993,000 | -0.5% | 9,775 | 0.0% | 0.02% | 0.0% |
| Q3 2016 | $998,000 | -15.3% | 9,775 | -1.0% | 0.02% | -11.8% |
| Q2 2016 | $1,178,000 | +18.6% | 9,875 | +6.5% | 0.02% | +30.8% |
| Q1 2016 | $993,000 | +2.1% | 9,275 | +3.3% | 0.01% | 0.0% |
| Q4 2015 | $973,000 | +31.0% | 8,975 | +3.5% | 0.01% | +30.0% |
| Q3 2015 | $743,000 | +10.1% | 8,675 | -31.7% | 0.01% | +25.0% |
| Q4 2014 | $675,000 | +9.8% | 12,700 | -3.1% | 0.01% | 0.0% |
| Q3 2014 | $615,000 | -37.1% | 13,100 | -16.6% | 0.01% | -33.3% |
| Q2 2014 | $977,000 | -1.8% | 15,700 | +6.1% | 0.01% | -7.7% |
| Q1 2014 | $995,000 | +16.1% | 14,800 | -9.2% | 0.01% | +18.2% |
| Q4 2013 | $857,000 | – | 16,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |